Cargando…

The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019

PURPOSE: The incidence and mortality rate of nasopharyngeal carcinoma (NPC) has changed in recent years. Our goal is to determine the epidemiological pattern of NPC to help policymakers allocate limited medical resources. METHODS: Detailed information about NPC from 2009 to 2019 was collected from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hao, Yin, Xin, Mao, Yiran, Chen, Meiqin, Tang, Qiuying, Yan, Senxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897385/
https://www.ncbi.nlm.nih.gov/pubmed/34146150
http://dx.doi.org/10.1007/s00405-021-06922-2
_version_ 1784663390116904960
author Yu, Hao
Yin, Xin
Mao, Yiran
Chen, Meiqin
Tang, Qiuying
Yan, Senxiang
author_facet Yu, Hao
Yin, Xin
Mao, Yiran
Chen, Meiqin
Tang, Qiuying
Yan, Senxiang
author_sort Yu, Hao
collection PubMed
description PURPOSE: The incidence and mortality rate of nasopharyngeal carcinoma (NPC) has changed in recent years. Our goal is to determine the epidemiological pattern of NPC to help policymakers allocate limited medical resources. METHODS: Detailed information about NPC from 2009 to 2019 was collected from the Global Burden of Disease 2019 database. Age-standardized rates (ASRs) and corresponding estimated annual percentage changes (EAPCs) were calculated to assess NPC’s incidence and mortality trends. RESULTS: Globally, there was a consistent increase in the NPC incidence cases from 2009 to 2019 (from 121.65 × 10(3) cases in 2009 to 176.50 × 10(3) cases in 2019, increasing by 45.09%). The age-standardized incidence rate (ASIR) of NPC increased from 1.81 in 2009 to 2.12 in 2019 (EAPC = 1.59, 95% CI 1.36–1.81). On the contrary, the mortality of NPC showed a downward trend (ASDR: 0.93 in 2009 and 0.86 in 2019; EAPC = − 0.63, 95% CI − 0.78 to − 0.48), and it was negatively correlated with the social demographic index (SDI) in most regions. Both incidence and mortality rates of high-incidence territories tended to be stable or decline. Males had significantly higher incidence and mortality of NPC than females. The number of patients with onset age greater than 50 years old accounted for the highest proportion. We found that smoking, occupational exposure to formaldehyde, and alcohol use were the main risk factors for NPC-related mortality. CONCLUSION: Globally, the incidence rate of NPC has been slightly increasing, while the mortality and disability-adjusted life years (DALYs) have been decreasing. NPC burden in high-middle and middle SDI areas was the heaviest. The current prevention strategy should be repositioned, and some countries should formulate more targeted approaches to reduce the current burden of NPC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00405-021-06922-2.
format Online
Article
Text
id pubmed-8897385
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88973852022-03-08 The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019 Yu, Hao Yin, Xin Mao, Yiran Chen, Meiqin Tang, Qiuying Yan, Senxiang Eur Arch Otorhinolaryngol Head and Neck PURPOSE: The incidence and mortality rate of nasopharyngeal carcinoma (NPC) has changed in recent years. Our goal is to determine the epidemiological pattern of NPC to help policymakers allocate limited medical resources. METHODS: Detailed information about NPC from 2009 to 2019 was collected from the Global Burden of Disease 2019 database. Age-standardized rates (ASRs) and corresponding estimated annual percentage changes (EAPCs) were calculated to assess NPC’s incidence and mortality trends. RESULTS: Globally, there was a consistent increase in the NPC incidence cases from 2009 to 2019 (from 121.65 × 10(3) cases in 2009 to 176.50 × 10(3) cases in 2019, increasing by 45.09%). The age-standardized incidence rate (ASIR) of NPC increased from 1.81 in 2009 to 2.12 in 2019 (EAPC = 1.59, 95% CI 1.36–1.81). On the contrary, the mortality of NPC showed a downward trend (ASDR: 0.93 in 2009 and 0.86 in 2019; EAPC = − 0.63, 95% CI − 0.78 to − 0.48), and it was negatively correlated with the social demographic index (SDI) in most regions. Both incidence and mortality rates of high-incidence territories tended to be stable or decline. Males had significantly higher incidence and mortality of NPC than females. The number of patients with onset age greater than 50 years old accounted for the highest proportion. We found that smoking, occupational exposure to formaldehyde, and alcohol use were the main risk factors for NPC-related mortality. CONCLUSION: Globally, the incidence rate of NPC has been slightly increasing, while the mortality and disability-adjusted life years (DALYs) have been decreasing. NPC burden in high-middle and middle SDI areas was the heaviest. The current prevention strategy should be repositioned, and some countries should formulate more targeted approaches to reduce the current burden of NPC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00405-021-06922-2. Springer Berlin Heidelberg 2021-06-19 2022 /pmc/articles/PMC8897385/ /pubmed/34146150 http://dx.doi.org/10.1007/s00405-021-06922-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Head and Neck
Yu, Hao
Yin, Xin
Mao, Yiran
Chen, Meiqin
Tang, Qiuying
Yan, Senxiang
The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019
title The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019
title_full The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019
title_fullStr The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019
title_full_unstemmed The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019
title_short The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019
title_sort global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the global burden of disease study 2019
topic Head and Neck
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897385/
https://www.ncbi.nlm.nih.gov/pubmed/34146150
http://dx.doi.org/10.1007/s00405-021-06922-2
work_keys_str_mv AT yuhao theglobalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT yinxin theglobalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT maoyiran theglobalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT chenmeiqin theglobalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT tangqiuying theglobalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT yansenxiang theglobalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT yuhao globalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT yinxin globalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT maoyiran globalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT chenmeiqin globalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT tangqiuying globalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019
AT yansenxiang globalburdenofnasopharyngealcarcinomafrom2009to2019anobservationalstudybasedontheglobalburdenofdiseasestudy2019